{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:59:10Z","timestamp":1779281950667,"version":"3.51.4"},"reference-count":0,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"vor","delay-in-days":395,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pigment Cell Research"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p>The molecular changes associated with the transition of melanoma cells from radial growth phase (RGP) to vertical growth phase [(VGP), metastatic phenotype] are not very well defined. We previously demonstrated that expression of the cell\u2010surface adhesion molecule MCAM\/MUC18 correlates directly with the metastatic potential of human melanoma cells. In addition, the progression of human melanoma towards the metastatic phenotype is associated with loss of expression of the tyrosine\u2010kinase receptor c\u2010KIT. In this review, I will summarize our recent studies demonstrating that the expression of both genes is regulated by the AP\u20102 transcription factor. Moreover, we have observed a loss of AP\u20102 expression in metastatic melanoma cells. Re\u2010expression of AP\u20102 in the highly metastatic A375SM cells decreased their tumorigenicity and inhibited their metastatic potential in nude mice. MCAM\/MUC18 mRNA and protein expression was significantly down\u2010regulated while c\u2010KIT expression was up\u2010regulated in the AP\u20102\u2010transfected cells. To further investigate the role of AP\u20102 in the progression of human melanoma, we attempted to inactivate AP\u20102 in primary cutaneous melanoma by using a dominant\u2010negative AP\u20102, or the AP\u20102B gene. Expression of AP\u20102B in SB\u20102 cells augmented their tumorigenicity in nude mice, and upregulated MMP\u20102 expression and activity. As AP\u20102 also regulates other genes that are involved in the progression of human melanoma such as E\u2010cadherin, p21\/WAF\u20101, HER2\/neu, Bcl\u20102, FAS\/APO\u20101, IGF\u2010R\u20101, VEGF and the thrombin receptor (PAR\u20101), we therefore propose that loss of AP\u20102 is a crucial event in the development of malignant melanoma. In addition, the transition of melanoma cells from RGP to VGP is also associated with over\u2010expression of the transcription factors CREB and ATF\u20101. The notion that the balance between AP\u20102 and CREB\/ATF\u20101 expression determines the progression of melanoma cells towards the metastatic phenotype will be discussed.<\/jats:p>","DOI":"10.1034\/j.1600-0749.2001.140202.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:36:07Z","timestamp":1047486967000},"page":"78-85","source":"Crossref","is-referenced-by-count":92,"title":["Gene Regulation in Melanoma Progression by the AP\u20102 Transcription Factor"],"prefix":"10.1111","volume":"14","author":[{"given":"MENASHE","family":"BAR\u2010ELI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,5]]},"container-title":["Pigment Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0749.2001.140202.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0749.2001.140202.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0749.2001.140202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:51:17Z","timestamp":1700412677000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0749.2001.140202.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1034\/j.1600-0749.2001.140202.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0749.2001.140202.x","archive":["Portico"],"relation":{},"ISSN":["0893-5785","1600-0749"],"issn-type":[{"value":"0893-5785","type":"print"},{"value":"1600-0749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}